Q3 2026

Filed Apr 13, 2026 · 10-Q · 44 days after period end · 0001493152-26-016388

Q3 2026 · 10-Q

Revenue

$987.00K

−11.8% vs Q3 2025

Net Income

-$1.31M

N/M vs Q3 2025

EPS Diluted

-$0.44

N/M vs Q3 2025

Gross Profit-$44,000N/M

Operating Income

Same quarter

Metric	Q3 2026	Q3 2025	Q3 2024	Q3 2023
Revenue	$987.00K	$1.12M	$1.02M	$1.11M
Net Income	-$1.31M	-$1.16M	-$1.92M	-$1.65M
EPS Diluted	-$0.44	-$0.48	-$0.11	-$0.12

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biomerica Inc · CIK 73290 · Engraved from SEC EDGAR